NVAX Stock Summary and Trading Ideas (Novavax | NASDAQ:NVAX)

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

What symbol and exchange does Novavax shares trade?

Novavax trades on the NASDAQ stock market under the symbol NVAX.

What is Novavax stock price doing today?

As of April 8, 2026, NVAX stock price climbed to $8.40 with 2,122,459 million shares trading.

What is Novavax's Beta?

NVAX has a beta of 1.39, meaning it tends to be more sensitive to market movements. NVAX has a correlation of 0.15 to the broad based SPY ETF.

How much is Novavax worth?

NVAX has a market cap of $1.36 billion. This is considered a Small Cap stock.

How much money does Novavax make?

Last quarter Novavax reported $147 million in Revenue and $.11 earnings per share. This beat revenue expectation by $62 million and exceeded earnings estimates by $.67.

What is the highest and lowest price Novavax traded in the last 3 year period?

In the last 3 years, NVAX traded as high as $23.86 and as low as $3.53.

What are the top ETFs holding Novavax?

The top ETF exchange traded funds that NVAX belongs to (by Net Assets): VTI, XBI, VB, IWM, VXF.

Is Novavax (NVAX) a good investment?

NVAX has underperformed the market in the last year with a price return of +28.4% while the SPY ETF gained +35.2%. However, in the short term, NVAX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.2% vs -1.9% return in SPY. But in the last 2 weeks, NVAX shares have been beat by the market, returning -9.3% compared to an SPY return of +3.3%.

What are the support and resistance levels for Novavax (NVAX)?

NVAX support price is $7.66 and resistance is $8.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVAX shares will trade within this expected range on the day.